| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/13/2007 | WO2007084856A9 Method for purifying polysaccharides |
| 09/13/2007 | WO2007073705A3 Pharmaceutical compositions containing protein nma0939 |
| 09/13/2007 | WO2007071786A3 Conjugate vaccines |
| 09/13/2007 | WO2007071707A3 Pneumococcal polysaccharide conjugate vaccine |
| 09/13/2007 | WO2007071692A3 Immunogenic composition |
| 09/13/2007 | WO2007063075A1 Induction of mucosal tolerance to antigens |
| 09/13/2007 | WO2007048022A3 Antibody-polypeptide fusion proteins and methods for producing and using same |
| 09/13/2007 | WO2007039070A3 Polynucleotides of haemophilus parasuis and its use |
| 09/13/2007 | WO2007038386A3 Method for enhancing immune responses in mammals |
| 09/13/2007 | WO2007033230A3 Anti-cd3 antibody formulations |
| 09/13/2007 | WO2007014179A3 Method for controlling immunodominance |
| 09/13/2007 | WO2006135447A3 Viral chimera compositions and methods |
| 09/13/2007 | WO2006116300A3 Methods of treating graft versus host disease |
| 09/13/2007 | WO2006113643A3 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies |
| 09/13/2007 | WO2006096487A3 Methods and compositions for modulating tweak and fn14 activity |
| 09/13/2007 | WO2006080867A8 Agent for stimulating the production of a blood coagulation factor viii |
| 09/13/2007 | WO2005040347A3 Methods and compositions for inhibiting cell growth and proliferation |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | US20070214512 Vector for genetically modifying non-human animals |
| 09/13/2007 | US20070213287 Introducing nucleic acid encoding therapeutic gene product formulated with an anionic polymer selected from polyglutamic acid, polyaspartic acid, polygalacturonic acid, poly vinyl sulfate into cell |
| 09/13/2007 | US20070212779 Targeting adenoviral vectors to dendritic cells |
| 09/13/2007 | US20070212753 Altered antibodies and their preparation |
| 09/13/2007 | US20070212743 Assays for Determining Anticoagulant Cofactor Activity |
| 09/13/2007 | US20070212737 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders |
| 09/13/2007 | US20070212727 Microorganisms for therapy |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212404 Liposome And Method Of Preparing The Same |
| 09/13/2007 | US20070212379 Adding an effective, non-toxic amount of an endogenous photosensitizer to the fluid and exposing the fluid to photoradiation sufficient to inactivate the infectious particles but not enough to damage the antigenic characteristics of the infectious particles |
| 09/13/2007 | US20070212378 Methods And Compositions For Mycoplasma Pneumoniae Exotoxins |
| 09/13/2007 | US20070212377 Viral particle comprising nucleotide sequences coding gB gene of infectious laryngotracheitis virus for use in generation of vaccine to prevent respiratory system disorders |
| 09/13/2007 | US20070212376 Method of treating and preventing infectious diseases |
| 09/13/2007 | US20070212375 Process For Producing In Yeast Empty Viral Capsids Consisting Of Proteins Derived From Pvp2 Of The Infectious Bursal Disease Virus (Ibdv) |
| 09/13/2007 | US20070212374 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus l1 proteins, and uses thereof |
| 09/13/2007 | US20070212373 Lawsonia Intracellularis 26 Kd Subunit Vaccine |
| 09/13/2007 | US20070212372 Methods for the treatment and prophylaxis of demeyelinating disease |
| 09/13/2007 | US20070212370 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 09/13/2007 | US20070212369 Colon Specific Genes and Proteins |
| 09/13/2007 | US20070212368 Proteins |
| 09/13/2007 | US20070212367 Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions |
| 09/13/2007 | US20070212366 Use Of Mrp4-Inhibitors For The Treatment And/Or Prophylaxis Of Cardiovascular Diseases |
| 09/13/2007 | US20070212365 recombinantly produced polypeptide; contacting a vascular cell with polypeptide for inhibiting angiogeneisis |
| 09/13/2007 | US20070212364 Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women |
| 09/13/2007 | US20070212363 Immunoglobulins with Potent and Broad Antiviral Activity |
| 09/13/2007 | US20070212362 Use of il-17 antibody for the treatment of cartilage damaged by osteoarthritis |
| 09/13/2007 | US20070212361 Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
| 09/13/2007 | US20070212360 Modulation of mitochondrial oxygen consumption for therapeutic purposes |
| 09/13/2007 | US20070212359 Cancer Diagnosis And Treatment Of Cancer Using Anti-Robo 1 Antibody |
| 09/13/2007 | US20070212358 Compositions and Methods for Effecting Controlled Posterior Vitreous Detachment |
| 09/13/2007 | US20070212357 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy |
| 09/13/2007 | US20070212356 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling |
| 09/13/2007 | US20070212355 GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and Uses |
| 09/13/2007 | US20070212354 Administering a therapeutically effective amount of a vascular endothelial growth factor (VEGF) antagonist dimeric protein comprising two fusion polypeptides |
| 09/13/2007 | US20070212353 Novel therapeutic target and diagnostic marker for asthma and related conditions |
| 09/13/2007 | US20070212352 Methods and compositions for the treatment of polycystic diseases |
| 09/13/2007 | US20070212351 Novel therapeutic targets in cancer |
| 09/13/2007 | US20070212350 Rs7 antibodies |
| 09/13/2007 | US20070212349 antibodies and antibody fragments that specifically bind a CD4-inducible HIV gp120 epitope that is enhanced by binding a co-receptor for HIV, such as chemokine receptors, used for inhibiting HIV entry into cells and inhibiting replication of HIV in mammals |
| 09/13/2007 | US20070212348 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 09/13/2007 | US20070212347 Compositions and methods for treating polycystic kidney disease gene |
| 09/13/2007 | US20070212346 Highly Concentrated Stabilized Igm Solution |
| 09/13/2007 | US20070212345 Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas |
| 09/13/2007 | US20070212337 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| 09/13/2007 | US20070212329 Vaccine Compositions Comprising An Interleukin 18 And Saponin Adjuvant System |
| 09/13/2007 | US20070212328 Immunogenic Compositions |
| 09/13/2007 | US20070212299 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response |
| 09/13/2007 | CA2645177A1 Hepatitis c virus non structural fusion protein |
| 09/13/2007 | CA2644906A1 Human and humanized cd22 antibodies and methods of use |
| 09/13/2007 | CA2644855A1 Extracorporeal removal of microvesicular particles |
| 09/13/2007 | CA2644782A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | CA2644774A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/13/2007 | CA2644421A1 Use of vx-702 for treating rheumatoid arthritis |
| 09/13/2007 | CA2644195A1 Mycoplasma hyopneumoniae vaccine |
| 09/13/2007 | CA2644170A1 Humanized anti-cd20 monoclonal antibody |
| 09/13/2007 | CA2644148A1 Angiogenesis pathway gene polymorphisms for therapy selection |
| 09/13/2007 | CA2644110A1 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/13/2007 | CA2644079A1 Methods and compositions for poxvirus a35r protein |
| 09/13/2007 | CA2644020A1 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/13/2007 | CA2643790A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 09/13/2007 | CA2638833A1 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 09/13/2007 | CA2638760A1 Compositions that include hemagglutinin, methods of making and methods of use thereof |
| 09/13/2007 | CA2631713A1 Modulators of cdc2-like kinases (clks) and methods of use thereof |
| 09/12/2007 | EP1832662A2 DNA encoding chondroitin synthase from Pasteurella multocida and methods of use |
| 09/12/2007 | EP1832656A1 Method for isolating and using fungal hemolysin |
| 09/12/2007 | EP1832655A2 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 09/12/2007 | EP1832653A1 MN gene and protein |
| 09/12/2007 | EP1832605A1 Neural cell adhesion molecule (NCAM) binding antibodies |
| 09/12/2007 | EP1832604A1 Use of IEX-1 for the treatment of glioma tumors |
| 09/12/2007 | EP1832603A2 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy |
| 09/12/2007 | EP1832602A1 Peptides which mimic the antigenic regions of the hepatitis a virus |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832297A1 Anticoagulant agents useful in treatment of thrombosis |
| 09/12/2007 | EP1831694A2 Eph receptor tumor biomarkers |
| 09/12/2007 | EP1831372A2 Neutralizing epitope-based growth enhancing vaccine |
| 09/12/2007 | EP1831357A1 Rescue of influenza virus |
| 09/12/2007 | EP1831259A2 Compositions of influenza viral proteins and methods of use thereof |
| 09/12/2007 | EP1831258A2 Monoclonal antibodies against nkg2a |
| 09/12/2007 | EP1831257A1 Humanized antibody specific for tumor necrosis factor-alpha |
| 09/12/2007 | EP1831256A1 Immunoglobulins comprising predominantly a galglcnacman5glcnac2 glycoform |
| 09/12/2007 | EP1831253A1 Combination therapy for b cell disorders |
| 09/12/2007 | EP1831248A1 Pasteurella multocida vaccine |